Hospital-acquired pneumonia: impact of the Curetis Unyvero system
The increasing prevalence of antimicrobial resistance and the burden of disease due to hospital-associated pneumonia prompted Emma Jones and colleagues to investigate a molecular alternative to microbiological culture.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.